IBDEI1NW ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27804,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,27805,0)
 ;;=Z85.71^^132^1321^78
 ;;^UTILITY(U,$J,358.3,27805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27805,1,3,0)
 ;;=3^Personal Hx of Hodgkin Lymphoma
 ;;^UTILITY(U,$J,358.3,27805,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,27805,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,27806,0)
 ;;=Z65.8^^132^1321^138
 ;;^UTILITY(U,$J,358.3,27806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27806,1,3,0)
 ;;=3^Psychosocial Circumstance Related Problems
 ;;^UTILITY(U,$J,358.3,27806,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,27806,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,27807,0)
 ;;=Z86.11^^132^1321^115
 ;;^UTILITY(U,$J,358.3,27807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27807,1,3,0)
 ;;=3^Personal Hx of Tuberculosis
 ;;^UTILITY(U,$J,358.3,27807,1,4,0)
 ;;=4^Z86.11
 ;;^UTILITY(U,$J,358.3,27807,2)
 ;;=^5063461
 ;;^UTILITY(U,$J,358.3,27808,0)
 ;;=Z86.13^^132^1321^82
 ;;^UTILITY(U,$J,358.3,27808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27808,1,3,0)
 ;;=3^Personal Hx of Malaria
 ;;^UTILITY(U,$J,358.3,27808,1,4,0)
 ;;=4^Z86.13
 ;;^UTILITY(U,$J,358.3,27808,2)
 ;;=^5063463
 ;;^UTILITY(U,$J,358.3,27809,0)
 ;;=Z86.73^^132^1321^112
 ;;^UTILITY(U,$J,358.3,27809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27809,1,3,0)
 ;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
 ;;^UTILITY(U,$J,358.3,27809,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,27809,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,27810,0)
 ;;=Z86.79^^132^1321^75
 ;;^UTILITY(U,$J,358.3,27810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27810,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,27810,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,27810,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,27811,0)
 ;;=Z91.040^^132^1321^64
 ;;^UTILITY(U,$J,358.3,27811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27811,1,3,0)
 ;;=3^Latex Allergy Status
 ;;^UTILITY(U,$J,358.3,27811,1,4,0)
 ;;=4^Z91.040
 ;;^UTILITY(U,$J,358.3,27811,2)
 ;;=^5063607
 ;;^UTILITY(U,$J,358.3,27812,0)
 ;;=Z98.89^^132^1321^120
 ;;^UTILITY(U,$J,358.3,27812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27812,1,3,0)
 ;;=3^Postprocedural States/Hx of Surgery NEC
 ;;^UTILITY(U,$J,358.3,27812,1,4,0)
 ;;=4^Z98.89
 ;;^UTILITY(U,$J,358.3,27812,2)
 ;;=^5063754
 ;;^UTILITY(U,$J,358.3,27813,0)
 ;;=Z92.3^^132^1321^79
 ;;^UTILITY(U,$J,358.3,27813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27813,1,3,0)
 ;;=3^Personal Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,27813,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,27813,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,27814,0)
 ;;=Z91.120^^132^1321^60
 ;;^UTILITY(U,$J,358.3,27814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27814,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Financial Hardship
 ;;^UTILITY(U,$J,358.3,27814,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,27814,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,27815,0)
 ;;=Z91.11^^132^1321^69
 ;;^UTILITY(U,$J,358.3,27815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27815,1,3,0)
 ;;=3^Noncompliance w/ Dietary Regimen
 ;;^UTILITY(U,$J,358.3,27815,1,4,0)
 ;;=4^Z91.11
 ;;^UTILITY(U,$J,358.3,27815,2)
 ;;=^5063611
 ;;^UTILITY(U,$J,358.3,27816,0)
 ;;=Z87.891^^132^1321^103
 ;;^UTILITY(U,$J,358.3,27816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27816,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,27816,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,27816,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,27817,0)
 ;;=Z77.090^^132^1321^11
 ;;^UTILITY(U,$J,358.3,27817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27817,1,3,0)
 ;;=3^Asbestos Contact/Exposure
